Resolutions adopted at the annual general meeting of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Resolutions adopted at the annual general meeting of Tribona AB

Lund, Sweden, 2015-04-22 16:00 CEST (GLOBE NEWSWIRE) --  

N.B. the English version below is an office translation. In case of any discrepancy between the Swedish and the English version, the Swedish version shall prevail.

The following resolutions, among others, were adopted by the annual general meeting of Tribona AB (publ) held on 22 April 2015:

Dividend

The annual general meeting resolved, in respect of the 2014 financial year, to affirm the appropriation of the company's profit as proposed by the board of directors and that a dividend be issued of SEK 0.50 per share, totalling SEK 24,328,526. 24 April 2015 was adopted as the record date for dividends and thus payment of dividends is expected to take place on 29 April 2015.

Discharge from liability

The annual general meeting granted the directors and CEO discharge from liability in respect of the 2014 financial year.

Board of directors and auditor

The annual general meeting resolved to re-elect Mats-Olof Ljungquist, Rutger Arnhult, Malin Rylander Leijon and Patrik Essehorn as directors and to elect Anneli Jansson as director. Mats-Olof Ljungquist was re-elected as chairman of the board. The shareholders at the annual general meeting resolved that, for the period until the next annual general meeting, fees shall be paid in the amount of SEK 150,000 to the chairman of the board and SEK 100,000 each to the other directors, which are the same fees as last year.

The annual general meeting re-elected the registered accounting firm Ernst & Young AB as the company's auditors. Remuneration according to an authorized account.

Authorization of the board of directors to issue shares

The annual general meeting resolved to authorize the board of directors to issue new shares, on one or more occasions prior to the next annual general meeting, with or without regard to shareholders’ pre-emption rights. The payment of issued shares may be in cash, by non-cash consideration, by set-off or otherwise subject to terms and conditions stated in The Swedish Companies Act, chapter 2 section 5, second paragraph, points 1-3 and 5. The number of shares to be issued pursuant to the authorization shall be limited to 10 per cent of the shares from time to time outstanding.

The chairman of the annual general meeting explained that the board of directors’ intention with this authorization is to exercise this authority only in connection with the acquisition of properties or companies that Tribona AB may undertake.

Authorization of the board of directors to acquire and transfer own shares

The annual general meeting resolved to authorise the board of directors, on one or more occasions during the period until the next annual general meeting, to decide on the acqusition or transfer of own shares.

Acquisition may be made (i) by an offer to all shareholders at a price equivalent to the stock quote when the offer is announced or (ii) by way of acquisition on Nasdaq Stockholm at a price within the price interval prevailing from time to time. The maximum number of shares to be acquired shall be such that the company’s holding from time to time does not exceed one tenth of all shares in the company.

Transfer may take place on Nasdaq Stockholm, with preference given to shareholders or, with deviation from the shareholders' pre-emption rights, to third parties. The payment for the transferred shares may be made in cash, by non-cash consideration, by set-off or otherwise subject to terms and conditions. Transfers may only be made with the number of shares the company from time to time holds. Transfers on Nasdaq Stockholm shall be made at a price within the prevailing price interval of Nasdaq Stockholm, i.e. the interval between the highest bid price and lowest ask price.

The purpose of the authorization is to improve the company's capital structure and to enable the transfer of shares in connection with financing of possible acquisitions.

Other resolutions 

In addition, resolutions also adopted regarding instructions for the nomination committee as well as guidelines regarding compensation to senior executives.

For further information:

Per Johansson, CEO: +46 708 17 13 63, email: per.johansson@tribona.se

The information in this press release comprises such information as Tribona AB (publ) is required to publish in accordance with the Securities Market Act or the Financial Instruments Trading Act. The information was provided for publication at 4.00 pm on 22 April 2015.

About Tribona
Tribona AB (publ) is one of Sweden's largest listed pure-play logistic property company. The property portfolio consists of modern and strategically located logistic properties, 29 in Sweden and one in Denmark, with a total lettable area of about 688 000 square meters. For more information, please visit www.tribona.se .



 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 306

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 288

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 392

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 343

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 451

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 216

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 295

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 289

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 487

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 152

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
d -->

Top 5 Most Recently Viewed Articles

Addressing the Housing Crisis: Federal Funding Efforts

Updated Category News Views 313

Tackling Canada's Housing Crisis Canada is actively working to combat its housing crisis, with significant measures aimed at helping those who are homeless. While there’s a sense of hope in the air, the presence of encampments underscores the immediate need for long-lasting solutions. The federal government is stepping up its efforts, showing a dedicated resolve to...

Continue Reading
Rigetti Computing Readies for Third Quarter Results Announcement

Updated Category News Views 65

Rigetti Computing Announces Third Quarter Financial Results Rigetti Computing, Inc. (Nasdaq: RGTI), recognized as a leader in hybrid quantum-classical computing, has exciting news regarding its financial performance. The company is set to release its financial results for the third quarter of 2024 on a specified date, marking an important moment for stakeholders and...

Continue Reading
Novartis Reports Outstanding Q3 Performance and 2025 Outlook

Updated Category News Views 545

Solid Q3 Performance by Novartis In a significant announcement, Novartis reported an impressive growth in net sales and core operating income for the third quarter. During this period, the company's net sales reached USD 13.9 billion, reflecting a growth of 7% on a constant currency basis and an 8% increase in USD terms. Core operating income showed a similar trajectory,...

Continue Reading
Forestar Group Inc. Set to Announce First Quarter Earnings Soon

Updated Category News Views 134

Forestar Group Inc. to Announce First Quarter Earnings Forestar Group Inc. (NYSE: FOR) is preparing to share key financial results for its first quarter, marking the end of December 2024. This eagerly awaited announcement will take place shortly before the markets open on the designated day. Shareholders and interested parties will have the opportunity to hear about the...

Continue Reading
ImCheck Therapeutics Secures EMA Orphan Drug Designation

Updated Category News Views 196

ImCheck Therapeutics Secures EMA Orphan Drug Designation ImCheck Therapeutics has exciting news as it recently announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to ICT01, its flagship treatment aimed at addressing acute myeloid leukemia (AML). This development, coming shortly after a similar designation from the U.S. FDA,...

Continue Reading